Comments
Loading...
Adverum Biotechnologies Earnings Estimates, EPS & Revenue | NASDAQ:ADVM | Benzinga
Adverum Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 4
EPS Estimate
$-1.380
Quarterly Revenue Estimate
$100.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$1.00M
Analyze the earnings history of Adverum Biotechnologies using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies | -$1.50 | -$1.33 | — | — | $0.00 | — | — | — | 05/08/2025 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.30 | -$1.38 | — | — | $0.00 | $100.00K | — | — | 04/04/2025 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.30 | -$1.31 | -$1.30 | 0.76% | $0.00 | $100.00K | $1.00K | -99.00% | 11/04/2024 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.10 | -$1.45 | -$0.89 | 38.62% | $0.00 | $110.00K | $0.00 | -100.00% | 08/12/2024 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.90 | -$1.41 | -$1.50 | -6.38% | $3.60M | — | $0.00 | — | 05/09/2024 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.30 | -$3.40 | -$2.30 | 32.35% | $0.00 | — | $0.00 | — | 03/18/2024 | Get Alert |
| ADVM | Adverum Biotechnologies | -$4.00 | -$3.20 | -$3.30 | -3.12% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| ADVM | Adverum Biotechnologies | -$4.40 | -$3.30 | -$3.10 | 6.06% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.80 | -$3.20 | -$2.90 | 9.38% | $0.00 | — | $3.60M | — | 05/11/2023 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.50 | -$3.60 | -$3.30 | 8.33% | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.90 | -$3.40 | -$4.00 | -17.65% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| ADVM | Adverum Biotechnologies | -$4.50 | -$3.40 | -$4.40 | -29.41% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.90 | — | -$3.80 | — | $7.50M | — | $0.00 | — | 05/12/2022 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.90 | -$3.40 | -$3.50 | -2.94% | $0.00 | — | $0.00 | — | 03/29/2022 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.10 | -$3.70 | -$3.90 | -5.41% | $0.00 | — | $0.00 | — | 11/04/2021 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.60 | -$3.80 | -$4.50 | -18.42% | $0.00 | $60.00K | $0.00 | -100.00% | 08/05/2021 | Get Alert |
| ADVM | Adverum Biotechnologies | -$3.10 | -$3.80 | -$2.90 | 23.68% | $0.00 | $60.00K | $7.50M | 12400.00% | 05/06/2021 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.90 | -$3.20 | -$3.90 | -21.88% | $0.00 | $80.00K | $0.00 | -100.00% | 03/01/2021 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.50 | — | -$3.10 | — | $250.00K | — | $0.00 | — | 11/05/2020 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.30 | -$2.80 | -$3.60 | -28.57% | $0.00 | $90.00K | $0.00 | -100.00% | 08/10/2020 | Get Alert |
| ADVM | Adverum Biotechnologies | -$2.30 | -$2.70 | -$3.10 | -14.81% | $0.00 | $90.00K | $0.00 | -100.00% | 05/28/2020 | Get Alert |
Adverum Biotechnologies (ADVM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $-1.30 | $-1.31 | 0.76 % |
| Q2 | 2024-08-12 | $-0.89 | $-1.45 | 38.6 % |
| Q1 | 2024-05-09 | $-1.50 | $-1.41 | -6.38 % |
| Q4 | 2024-03-18 | $-2.30 | $-3.40 | 32.4 % |
Adverum Biotechnologies (ADVM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $1.00K | $100.00K | -99.0 % |
| Q2 | 2024-08-12 | $0 | $110.00K | -100.0 % |
| Q2 | 2021-08-05 | $0 | $60.00K | -100.0 % |
| Q1 | 2021-05-06 | $7.50M | $60.00K | 12400.0 % |
FAQ
When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?
Adverum Biotechnologies (ADVM) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
What were the latest earnings per share (EPS) for Adverum Biotechnologies (NASDAQ:ADVM)?
The Actual EPS was $-1.30, which beat the estimate of $-1.31.
What were Adverum Biotechnologies’s (NASDAQ:ADVM) revenues?
The Actual Revenue was $1K, which missed the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.